Xyzal and Xifaxan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xyzal (levocetirizine dihydrochloride) and Xifaxan (rifaximin). Common drug interactions include dizziness among females and hospitalisation among males.

The phase IV clinical study analyzes what interactions people have when they take Xyzal and Xifaxan. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Xyzal?

Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 21,479 Xyzal users. Check the latest studies of Xyzal.

What is Xifaxan?

Xifaxan has active ingredients of rifaximin. It is often used in irritable bowel syndrome. eHealthMe is studying from 16,609 Xifaxan users. Check the latest studies of Xifaxan.



On May, 15, 2026

34 people who take Xyzal and Xifaxan together, and have interactions are studied.

Xyzal and Xifaxan drug interactions.

What are the common drug interactions of Xyzal and Xifaxan, by gender? *:

female:

  1. Dizziness
  2. Fatigue (feeling of tiredness)
  3. Insomnia (sleeplessness)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Nausea (feeling of having an urge to vomit)
  6. Neuropathy peripheral (surface nerve damage)
  7. Polyarthritis (arthritis which involves 5 or more joints simultaneously)
  8. Rectal abscess (pus in rectum)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Abdominal pain upper

male:

  1. Hospitalisation
  2. Pruritus (severe itching of the skin)
  3. Scab (a hard coating on the skin formed during the wound healing)

What are the common drug interactions of Xyzal and Xifaxan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pruritus (severe itching of the skin)
  2. Scab (a hard coating on the skin formed during the wound healing)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Breast cancer
  2. Abdominal pain upper
  3. Blood immunoglobulin g decreased
  4. Blood immunoglobulin m decreased
  5. Cd4 lymphocytes decreased
  6. Constipation
  7. Diarrhoea
  8. Disease recurrence
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

60+:

  1. Anorectal disorder
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Coeliac disease (simple food intolerance)
  5. Dehydration (dryness resulting from the removal of water)
  6. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  7. Dizziness
  8. Drug administration error
  9. Drug effect decreased
  10. Ear haemorrhage (bleeding from ear)

What are the existing conditions these people have? *

  1. Sleep Disorder: 12 people, 35.29%
  2. Hereditary Angioedema (recurrent episodes of severe swelling): 6 people, 17.65%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 11.76%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 11.76%
  5. Hypersensitivity: 3 people, 8.82%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.88%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 5.88%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Xyzal and Xifaxan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xyzal and Xifaxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xyzal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xifaxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xyzal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xifaxan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levocetirizine dihydrochloride and rifaximin (the active ingredients of Xyzal and Xifaxan, respectively), and Xyzal and Xifaxan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: